卖什么
AI Virtual Cell foundation models (OCOO) plus automated cell experiments to predict cellular responses to genetic, chemical and environmental perturbations.
商业模式拆解
买家：谁掌握预算？
未核实Head of discovery / R&D at pharma and biotech companies.
触发点：什么让他们现在购买？
未核实Pharma and biotech teams needing faster disease-mechanism research, target discovery and drug screening than wet-lab-only methods.
工作流：什么输入变成什么输出？
Computational prediction, then in-vitro validation, then model iteration in a closed loop supporting target discovery and drug screening.
经济账：省了什么，怎么收费？
未核实Not stated; likely research collaboration or model/platform service fees for drug discovery partners.
渠道：怎么接触到客户？
Incubated by XtalPi (2228.HK) in Beijing; partnership and contact-led (site has Contact page only).
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-06-01 | 天使轮 | 数千万元 | — | wap.eastmoney.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.